News
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Delivering Eye-Popping Gains. Hims & Hers rebounded by 11.76 ...
Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...
StockStory.org on MSN18h
Stocks making big moves this week: Torrid, Provident Financial Services, Bumble, Coinbase, and Hims & Hers HealthRegional bank Provident Financial Services (NYSE:PFS) rose by 5.8% on Thursday after Raymond James initiated coverage on the ...
Hims & Hers' (NYSE: HIMS) stock crashed over 30% following news highlighting the end of its relationship with Novo Nordisk ...
On April 29, 2025, Hims announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of "a bundled offering of Novo Nordisk's FDA-approved Wegovy on the Hims & Hers platform ...
Zacks.com on MSN14h
Barclays vs. HSBC: Which Global Bank is the Smarter Buy Today?Detailed price information for Barclays Plc ADR (BCS-N) from The Globe and Mail including charting and trades.
View the most recent data and latest information on option chains for Hims & Hers Health, Inc. Class A Common Stock (HIMS) at Nasdaq.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback